Posted on 1/16/17
Retro Fitness Sprints Up Entrepreneur’s Franchise 500 List to No. 119
COLTS NECK, N.J.--(BUSINESS WIRE)--Retro Fitness climbs 123 spots to No. 119 in Entrepreneur Magazine’s newly released “Franchise 500” ranking for 2017.Noted as the world’s first, best . . .
Posted on 1/26/17
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part V
Brought to you by Offit Kurman Attorneys At Law
Posted on 1/25/17
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part IV
Brought to you by Offit Kurman Attorneys At Law
Posted on 1/23/17
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part III
Brought to you by Offit Kurman Attorneys At Law
Posted on 1/19/17
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part II
Brought to you by Offit Kurman Attorneys At Law
Posted on 1/17/17
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part I
Brought to you by Offit Kurman Attorneys At Law
Posted on 1/13/17
Vertex And German Merck Find Their Perfect Fit
It is difficult not to see yesterday’s licensing deal between Vertex (NASDAQ:VRTX) and Merck KGaA (MGKAF) (MGKAY) as a decent match. The US biotech had made . . .
Posted on 1/12/17
Merck Muscles Into Bristol's Combo Space
Acceptance of an additional regulatory filing is normally a footnote. The exception to this rule is Merck & Co. (NYSE:MRK), whose market cap this morning gained . . .
Posted on 1/12/17
Why Novartis Dropped 15.1% in 2016
IMAGE SOURCE: GETTY IMAGES.What happenedInvestors in the Swiss pharma giant Novartis (NYSE:NVS) had a rough 2016. The company's stock swooned by more than 15% during the . . .
Posted on 1/12/17
Celgene Is On Its Way To $196
Celgene (NASDAQ:CELG) is a company that doesn't stop impressing. This company is a beacon of hope for society as few companies are making so much progress . . .
Posted on 1/12/17
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
It's always fun to hear what pharmaceutical company executives might say at the J. P. Morgan (NYSE: JPM) Healthcare Conference. This year, Pfizer (NYSE:PFE) was represented . . .
Posted on 1/12/17
AmerisourceBergen (ABC) Presents At J.P. Morgan Healthcare Conference
The following slide deck was published by AmerisourceBergen Corporation in conjunction with this event.READ FULL ARTICLE HERE
Posted on 1/12/17
Johnson & Johnson: Should It Be In Your 2017 Dividend Portfolio?
AnalysisJohnson & Johnson's Cash Pile Could Come HomeAs the United States makes ready for the inauguration of President-Elect Trump, companies like Johnson & Johnson (NYSE:JNJ) are . . .
Posted on 1/11/17
Johnson & Johnson: Too Big To Break Up
It appears that it will take a major activist to shake things up at the $300 billion-plus market cap healthcare giant Johnson & Johnson (NYSE:JNJ). The . . .
Posted on 1/11/17
Can Johnson & Johnson Upset Chevron In The Divisional Round?
In the divisional round of the Dow Industrials Playoffs we have # 12 seeded Johnson & Johnson (NYSE:JNJ) taking on # 4 seeded Chevron Corporation (NYSE:CVX). . . .
Posted on 1/11/17
Johnson & Johnson Stock Split: Coming in 2017?
Few companies have the brand awareness and breadth of healthcare conglomerate Johnson & Johnson (NYSE:JNJ). The Dow component is well-known for its Band-Aid and Tylenol brands . . .
Posted on 1/11/17
1 Perfect Stock to Invest in the Pharmaceutical Industry
The pharmaceutical industry remains one of the fastest growing fields due to an aging global population and an unprecedented level of innovation that's bringing numerous game-changing . . .
Posted on 1/11/17
What's Next For Celgene
Celgene Corp.'s (NASDAQ:CELG) management took to the stage at the annual JP Morgan healthcare conference to outline to industry watchers its plans for the future. The . . .
Posted on 1/10/17
Why Celldex Therapeutics Imploded in 2016
What happenedAccording to data from S&P Global Market Intelligence, Celldex Therapeutics(NASDAQ:CLDX), a clinical-stage biotech, lost approximately three-quarters of its value last year.CLDX DATA BY YCHARTSThe biotech's . . .
Posted on 1/10/17
2 Reasons Pfizer's Stock Beat the Field in 2016
What happenedAccording to data from S&P Global Market Intelligence , Pfizer's (NYSE:PFE) shares gained 1.66% in 2016. While such a modest gain may not seem impressive . . .
Posted on 1/10/17
Is Celgene Simply the Best Biotech Stock on the Planet?
A mic drop at the end of Celgene (NASDAQ:CELG) CEO Mark Alles' presentation at the 35th Annual J.P. Morgan (NYSE: JPM) Healthcare Conference might have been . . .
Posted on 1/10/17
Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), a developer of rapid health information technologies, today announces the entry into an agreement relating to the sale of . . .
Posted on 1/10/17
Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
Sanofi and ImmuNext, Inc., announced today an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases . . .
Posted on 1/9/17
Advaxis Provides 2017 Business Outlook
PRINCETON, N.J., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today issued its 2017 business outlook to provide . . .
Posted on 1/9/17
Johnson & Johnson Medical Devices Companies Launch CareAdvantage
To help health systems navigate the impact of the changing health care landscape and optimize patient care, there's now CareAdvantage from the Johnson & Johnson Medical . . .
Philadelphia
